Blue Bell Private Wealth Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-723
Closed -$6.82K 735
2025
Q1
$6.82K Hold
723
﹤0.01% 548
2024
Q4
$8.9K Hold
723
﹤0.01% 506
2024
Q3
$10.8K Hold
723
﹤0.01% 517
2024
Q2
$9.76K Hold
723
﹤0.01% 524
2024
Q1
$12K Sell
723
-698
-49% -$11.6K ﹤0.01% 505
2023
Q4
$19.1K Sell
1,421
-287
-17% -$3.87K ﹤0.01% 433
2023
Q3
$18.7K Buy
1,708
+1
+0.1% +$11 0.01% 368
2023
Q2
$22.1K Hold
1,707
0.01% 346
2023
Q1
$20.5K Hold
1,707
0.01% 317
2022
Q4
$23.4K Sell
1,707
-200
-10% -$2.75K 0.01% 294
2022
Q3
$28K Hold
1,907
0.01% 261
2022
Q2
$29K Hold
1,907
0.01% 262
2022
Q1
$34K Hold
1,907
0.01% 256
2021
Q4
$45K Buy
1,907
+533
+39% +$12.6K 0.01% 216
2021
Q3
$42K Sell
1,374
-500
-27% -$15.3K 0.01% 109
2021
Q2
$60K Hold
1,874
0.02% 106
2021
Q1
$56K Buy
1,874
+440
+31% +$13.1K 0.02% 110
2020
Q4
$50K Sell
1,434
-410
-22% -$14.3K 0.02% 102
2020
Q3
$51K Hold
1,844
0.02% 105
2020
Q2
$50K Sell
1,844
-100
-5% -$2.71K 0.02% 100
2020
Q1
$38K Hold
1,944
0.02% 106
2019
Q4
$46K Sell
1,944
-100
-5% -$2.37K 0.02% 111
2019
Q3
$38K Hold
2,044
0.02% 114
2019
Q2
$43K Hold
2,044
0.02% 110
2019
Q1
$43K Sell
2,044
-16
-0.8% -$337 0.02% 112
2018
Q4
$39K Hold
2,060
0.02% 112
2018
Q3
$51K Buy
2,060
+410
+25% +$10.2K 0.02% 115
2018
Q2
$40K Buy
1,650
+250
+18% +$6.06K 0.02% 123
2018
Q1
$40K Hold
1,400
0.02% 130
2017
Q4
$33K Buy
1,400
+390
+39% +$9.19K 0.01% 134
2017
Q3
$27K Sell
1,010
-190
-16% -$5.08K 0.01% 141
2017
Q2
$28K Buy
1,200
+400
+50% +$9.33K 0.01% 148
2017
Q1
$19K Hold
800
0.01% 158
2016
Q4
$17K Hold
800
0.01% 166
2016
Q3
$21K Hold
800
0.01% 284
2016
Q2
$19K Buy
800
+400
+100% +$9.5K 0.01% 296
2016
Q1
$9K Hold
400
0.01% 363
2015
Q4
$11K Buy
+400
New +$11K 0.01% 361